|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 157.40 USD | -1.29% |
|
+9.95% | -5.56% |
| 11-18 | B. Riley Adjusts Price Target on Onto Innovation to $180 From $173, Maintains Buy Rating | MT |
| 11-17 | Onto Innovation Inc. Updates Revenue Guidance for the Fourth Quarter Ending January 3, 2026 | CI |
| Fiscal Period: December | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
Revenues | 556M | 789M | 1.01B | 816M | 987M | |||||
Total Revenues | 556M | 789M | 1.01B | 816M | 987M | |||||
Cost of Goods Sold, Total | 267M | 359M | 466M | 396M | 472M | |||||
Gross Profit | 289M | 429M | 539M | 420M | 515M | |||||
Selling General & Admin Expenses, Total | 113M | 125M | 135M | 145M | 162M | |||||
R&D Expenses | 84.58M | 96.12M | 112M | 104M | 117M | |||||
Amortization of Goodwill and Intangible Assets - (IS) | 53.75M | 51.37M | 55.28M | 54.82M | 49.44M | |||||
Other Operating Expenses, Total | 252M | 273M | 303M | 304M | 328M | |||||
Operating Income | 37.36M | 157M | 237M | 116M | 187M | |||||
Interest Expense, Total | - | - | - | - | - | |||||
Interest And Investment Income | 2.9M | 1.16M | 5.01M | 20.36M | 33.49M | |||||
Net Interest Expenses | 2.9M | 1.16M | 5.01M | 20.36M | 33.49M | |||||
Currency Exchange Gains (Loss) | -3.07M | -2.02M | -73K | -4.09M | -276K | |||||
Other Non Operating Income (Expenses) | 362K | 132K | -68K | 239K | 131K | |||||
EBT, Excl. Unusual Items | 37.55M | 156M | 242M | 133M | 220M | |||||
Restructuring Charges | - | - | - | - | - | |||||
Merger & Related Restructuring Charges | -10.68M | -393K | - | - | - | |||||
Gain (Loss) On Sale Of Assets | - | - | - | - | - | |||||
Asset Writedown | - | - | - | - | - | |||||
Insurance Settlements | - | - | - | - | - | |||||
Legal Settlements | - | - | - | - | - | |||||
Other Unusual Items | - | - | - | - | - | |||||
EBT, Incl. Unusual Items | 26.87M | 156M | 242M | 133M | 220M | |||||
Income Tax Expense | -4.16M | 13.33M | 18.25M | 11.42M | 18.78M | |||||
Earnings From Continuing Operations | 31.02M | 142M | 223M | 121M | 202M | |||||
Net Income to Company | 31.02M | 142M | 223M | 121M | 202M | |||||
Net Income - (IS) | 31.02M | 142M | 223M | 121M | 202M | |||||
Net Income to Common Incl Extra Items | 31.02M | 142M | 223M | 121M | 202M | |||||
Net Income to Common Excl. Extra Items | 31.02M | 142M | 223M | 121M | 202M | |||||
Per Share Items | ||||||||||
Net EPS - Basic | 0.63 | 2.89 | 4.52 | 2.47 | 4.09 | |||||
Basic EPS - Continuing Operations | 0.63 | 2.89 | 4.52 | 2.47 | 4.09 | |||||
Basic Weighted Average Shares Outstanding | 49.14M | 49.24M | 49.42M | 48.97M | 49.34M | |||||
Net EPS - Diluted | 0.63 | 2.86 | 4.49 | 2.46 | 4.06 | |||||
Diluted EPS - Continuing Operations | 0.63 | 2.86 | 4.49 | 2.46 | 4.06 | |||||
Diluted Weighted Average Shares Outstanding | 49.48M | 49.73M | 49.76M | 49.32M | 49.66M | |||||
Normalized Basic EPS | 0.48 | 1.98 | 3.05 | 1.69 | 2.79 | |||||
Normalized Diluted EPS | 0.47 | 1.96 | 3.03 | 1.68 | 2.77 | |||||
Supplemental Items | ||||||||||
EBITDA | 105M | 223M | 301M | 183M | 249M | |||||
EBITA | 91.1M | 208M | 292M | 171M | 237M | |||||
EBIT | 37.36M | 157M | 237M | 116M | 187M | |||||
EBITDAR | 112M | 229M | 308M | 190M | 256M | |||||
Effective Tax Rate - (Ratio) | -15.47 | 8.56 | 7.55 | 8.62 | 8.52 | |||||
Current Domestic Taxes | 1.84M | 22.8M | 48.95M | 29.2M | 41.84M | |||||
Current Foreign Taxes | 5.64M | 3.15M | 2.9M | 4.65M | 3.41M | |||||
Total Current Taxes | 7.47M | 25.95M | 51.85M | 33.85M | 45.25M | |||||
Deferred Domestic Taxes | -11.39M | -10.02M | -33.13M | -22.19M | -26.16M | |||||
Deferred Foreign Taxes | -240K | -2.6M | -473K | -242K | -318K | |||||
Total Deferred Taxes | -11.63M | -12.62M | -33.6M | -22.43M | -26.48M | |||||
Normalized Net Income | 23.47M | 97.55M | 151M | 82.86M | 138M | |||||
Interest on Long-Term Debt | - | - | - | - | - | |||||
Supplemental Operating Expense Items | ||||||||||
Selling and Marketing Expenses | 48.14M | 57.24M | 65.69M | 61.76M | 76.16M | |||||
General and Administrative Expenses | 65.31M | 67.96M | 69.58M | 83.15M | 85.85M | |||||
Research And Development Expense From Footnotes | 84.58M | 96.12M | 112M | 104M | 117M | |||||
Net Rental Expense, Total | 6.76M | 5.96M | 6.37M | 6.53M | 6.4M | |||||
Imputed Operating Lease Interest Expense | - | - | - | - | - | |||||
Imputed Operating Lease Depreciation | - | - | - | - | - | |||||
Stock-Based Comp., COGS (Total) | - | - | - | - | 4.77M | |||||
Stock-Based Comp., R&D Exp. (Total) | - | - | - | - | 5.5M | |||||
Stock-Based Comp., S&M Exp. (Total) | - | - | - | - | 5.61M | |||||
Stock-Based Comp., G&A Exp. (Total) | - | - | - | - | 12.7M | |||||
Stock-Based Comp., SG&A Exp. (Total) | - | - | - | - | - | |||||
Stock-Based Comp., Other (Total) | 17.66M | 19.54M | 24.43M | 25.51M | - | |||||
Total Stock-Based Compensation | 17.66M | 19.54M | 24.43M | 25.51M | 28.58M |
- Stock Market
- Equities
- ONTO Stock
- Financials Onto Innovation Inc.
- Income Statement
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















